Armenian-American Noubar Afeyan’s Moderna soars after breakthrough cancer vaccine results

(Horizon Media / CAMBRIDGE, Mass.) — Moderna shares soared on Wednesday after the biotechnology company announced positive results from a pivotal late-stage trial of its experimental personalized cancer vaccine, marking a potentially significant breakthrough for mRNA technology beyond infectious diseases. The ...